Loading data
TMCINasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 212.69 m USD | 209.36 m USD | 187.12 m USD | 141.84 m USD | 94.42 m USD |
| Cost of revenue | 42.94 m USD | 41.09 m USD | 35.18 m USD | 25.53 m USD | 16.89 m USD |
| Gross profit | 169.75 m USD | 168.26 m USD | 151.94 m USD | 116.31 m USD | 77.53 m USD |
| Research and development expense | 20.28 m USD | 20.59 m USD | 15.44 m USD | 13.58 m USD | 10.2 m USD |
| Operating profit | -54.15 m USD | -55.69 m USD | -51.43 m USD | -34.84 m USD | -16.51 m USD |
| Interest expense | 5.32 m USD | 5.26 m USD | 5.17 m USD | 4.4 m USD | 4.06 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | — | — |
| Net income (reported basis) | -59 m USD | -56 m USD | -50 m USD | -43 m USD | -20.55 m USD |
| Net income attributable to common shareholders | — | — | -49.53 m USD | -42.82 m USD | -20.75 m USD |
| Basic earnings per share | -0.93 USD/share | -0.9 USD/share | -0.81 USD/share | -0.77 USD/share | -0.43 USD/share |
| Diluted earnings per share | -0.93 USD/share | -0.9 USD/share | -0.81 USD/share | -0.77 USD/share | -0.43 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.